Podcast
Monty Pal
At the Crossroads of Cancer and Metabolism
Clips
Summary
Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.
In this episode of On the Edge of Breakthrough, host Dr. Monty Pal sits down with Dr. Charles Brenner, an internationally recognized expert in metabolism and the founding Chair of the Department of Diabetes & Cancer Metabolism at City of Hope. Together, they explore the metabolic links between diabetes, obesity, and cancer, and how understanding those connections could lead to new ways to prevent and treat multiple diseases.
Dr. Brenner shares insights from his research into lean fatty liver disease (otherwise known as metabolic dysfunction-associated steatotic liver disease or MASLD), and how certain genetic factors may be quietly driving both metabolic dysfunction and cancer risk. They also discuss the rise of GLP-1 therapies and how a new class of compounds targeting FGF21 might offer a potential new therapeutic option that could help curb sugar cravings and support liver health.
This episode takes listeners deep into the science of energy balance, NAD metabolism, fatty liver disease, and what it truly means to be on the edge of a breakthrough.
Related Topics
You May Also Like
Monty Pal
Podcast
Monty Pal
Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.
Article
Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
Press Release
OVN Staff
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
Press Release
OVN Staff
Introducing OncologyVoiceNetwork.com
Article
A. Haslam, M.S. Kim, V. Prasad